Experience of hepatitis C testing among injecting drug users in Sydney, Australia

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 20, Issue 1, 2008, Pages 116-123

  Day, C A ^a,b   White, B ^a   Thein, H H ^a   Doab, A ^a   Dore, G J ^a   Bates, A ^a   Holden, J ^a   Maher, L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY; ARTICLE; AUSTRALIA; DELAYED DIAGNOSIS; DEMOGRAPHY; DRUG DEPENDENCE TREATMENT; EXPERIENCE; FEMALE; GENERAL PRACTICE; HEALTH CARE ACCESS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION PREVENTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; PATIENT ATTITUDE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; SEROPREVALENCE; SEXUAL COUNSELING; VIRUS DETECTION; VIRUS DIAGNOSIS;

ADULT; AIDS SERODIAGNOSIS; AUSTRALIA; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH BEHAVIOR; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 39349114835     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120701426524     Document Type: Article

References (21)

1. Aceijas, C., Stimson, G.V., Hickman, M., Rhodes, T. on behalf of The United Nations Reference Group on HIV/AIDS Prevention and Care Among IDU in Developing and Transistional Countries (2004). Global overview of injecting drug use and HIV infection among injecting drug users. AIDS, 18, 2295-2304.
2. Aitken, C.K., Kerger, M., & Crofts, N. (2002). Peer-delivered hepatitis C testing and counselling: A means of improving the health of injecting drug users. Drug and Alcohol Review, 21, 33-37.
3. Black, E., Degenhardt, L., & Stafford, J. (2006). NSW drug trends 2005: Findings from the Illicit Drug Reporting System (IDRS). Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
4. Carpenter, C.C.J., Cooper, D.A., Fischl, M.A., Gatell, J.M., Gazzard, B.G., Hammer, S.M., et al. (2000). Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society - US panel. Journal of the American Medical Association, 283, 381-390.
5. Day, C., & Dolan, K. (2006). Correlates of hepatitis C testing among heroin users in Sydney. Health Promotion Journal of Australia, 17, 70-72.
6. Day, C., Ross, J., & Dolan, K. (2003). Hepatitis C related discrimination among heroin users in Sydney: Drug user or hepatitis C discrimination? Drug and Alcohol Review, 22, 316-320.
7. Des Jarlais, D.C., Friedman, S.R., Friedmann, P., Wenston, J., Sotheran, J.L., Choopanya, K., et al. (1995). HIV/AIDS-related behavior change among injecting drug users in different national settings. AIDS, 9, 611-617.
8. Doab, A., Treloar, C., & Dore, G.J. (2005). Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia. Clinical Infectious Diseases, 40, S313-S320.
9. Dore, G.J., Freeman, A.J., Law, M., & Kaldor, J.M. (2003). Natural history models for hepatitis C-related liver disease: Different disease progression parameters for different settings. Antiviral Therapy, 8, 365-372.
10. Gibson, D.R., Mccusker, J., & Chesney, M. (1998). Effectiveness of psychosocial interventions in preventing HIV risk behaviour in injecting drug users. AIDS, 12, 919-929.
11. Jaeckel, E., Cornberg, M., Wedemeyer, H., Santantonio, T., Mayer, J., Zankel, M., et al., & German Acute Hepatitis C Therapy Group (2001). Treatment of acute hepatitis C with interferon Alpha-2b. New England Journal of Medicine, 345, 1452-1457.
12. Kamal, S.M., Moustafa, K.N., Chen, J., Fehr, J., Moneim, A.A., Khalifa, K.E., et al. (2006). Duration of Peginterferon therapy in acute hepatitis C: A randomized trial. Hepatology, 43, 923-931.
13. Kim, W.R. (2002). Global epidemiology and burden of hepatitis C. Microbes and Infection, 4, 1219-1225.
14. Kwiatkowski, C.F., Fortuin Corsi, K., & Booth, R.E. (2002). The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction, 97, 1289-1294.
15. Maher, L., Chant, K., Jalaludin, B., & Sargent, P. (2004). Risk behaviours and antibody hepatitis B and C prevalence among injecting drug users in South Western Sydney, Australia. Journal of Gastroenterology and Hepatology, 19, 1114-1120.
16. National Centre in HIV Epidemiology and Clinical Research (2005). Australian NSP Survey: National data report 2000-2004. Sydney, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales.
17. Spielberg, F., Branson, B.M., Goldbaum, G.M., Lockhart, D., Kurth, A., Celum, C. L., et al. (2003). Overcoming barriers to HIV testing: Preferences for new strategies among clients of a needle exchange, a sexually transmitted disease clinic and sex venues for men who have sex with men. Journal of Acquired Immune Deficiency Syndromes, 32, 318-328.
18. Stoove, M.A., Gifford, S.M., & Dore, G. J. (2005). The impact of injecting drug use status on hepatitis C-related referral and treatment. Drug and Alcohol Dependence, 77, 81-86.
19. Weinhardt, L.S., Carey, M.P., Johnson, B.T., & Bickham, N.L. (1999). Effects of HIV counselling and testing on sexual risk behavior: A meta-analytic review of published research, 1985-1997. American Journal of Public Health, 89, 1397-1405.
20. White, B., Day, C., Degenhardt, L., Kinner, S., Fry, C., Bruno, R., et al. (2006). Prevalence of injecting drug use and associated risk behaviour among regular ecstasy users in Australia. Drug and Alcohol Dependence, 83, 210-217.
21. Winstock, A.R., Anderson, C.M., & Sheridan, J. (2006). National survey of HIV and hepatitis testing and vaccination services provided by drug and alcohol agencies in Australia. Medical Journal of Australia, 184, 560-562.